Advanced Biomed Inc. (ADVB) vs T2 Biosystems, Inc. (TTOO)

Advanced Biomed Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $10.4M against $6.5M — 1.6× the size. T2 Biosystems, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 1.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −559.5%) and the lower return on invested capital (−29.3% vs 0.00%). Across the 11 metrics below, Advanced Biomed Inc. leads on 6 and T2 Biosystems, Inc. on 5.

Valuation

Metric ADVB TTOO Diagnostics & Research median
P/E 1.35 n/m 33.95
P/S n/m n/m 4.87
P/B 0.91 n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales n/m 0.64 5.66
Earnings yield 74.15% 0.00% (1.75%)
Free cash flow yield (35.24%) 0.00% (0.13%)

Profitability

Metric ADVB TTOO Diagnostics & Research median
Gross margin — (76.76%) 50.89%
Operating margin 0.00% (542.59%) (8.57%)
Net margin 0.00% (559.52%) (6.37%)
Free cash flow margin 0.00% (476.64%) 0.00%
Return on equity 79.17% 277.61% (2.92%)
Return on assets 55.78% (140.00%) (6.71%)
Return on invested capital (29.27%) 0.00% 0.00%

Growth

Metric ADVB TTOO Diagnostics & Research median
Revenue growth (TTM) — (30.19%) 7.69%
EPS growth (last fiscal year) (15.01%) 98.44% —
Revenue growth, 5-year CAGR — (7.29%) 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB TTOO Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 7.38 0.40 2.02
Net debt to EBITDA 1.08 0.32 0.78

Dividend

Metric ADVB TTOO Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric ADVB TTOO Diagnostics & Research median
Market cap 10.42m 6.48m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack